Monika Peeters Selected Research

Monika Peeters Research Topics

16	Infections 01/2017 - 07/2010
6	Chronic Hepatitis C 01/2016 - 02/2014
5	Fatigue 12/2014 - 06/2014
5	Exanthema (Rash) 08/2014 - 11/2009
3	Hepatitis C 02/2016 - 01/2011
3	Fibrosis (Cirrhosis) 01/2016 - 01/2011
3	Headache (Headaches) 12/2014 - 08/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2009 - 03/2007
1	Liver Diseases (Liver Disease) 05/2016
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Rhabdomyolysis 09/2015
1	Chronic Renal Insufficiency 09/2015
1	Coinfection 12/2014
1	Nausea 12/2014
1	Neutropenia 12/2014
1	Hyperbilirubinemia 12/2013
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2008
1	Disease Progression 03/2007

18	SimeprevirIBA 01/2017 - 01/2011
12	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2011
11	Protease Inhibitors (Protease Inhibitor)IBA 02/2016 - 06/2012
6	InterferonsIBA 08/2014 - 01/2011
4	etravirine (TMC-125)FDA Link 10/2010 - 03/2007
2	SofosbuvirIBA 01/2016 - 01/2016
2	Interferon alpha-2 (Roferon-A)FDA Link 08/2014 - 08/2014
1	daclatasvirIBA 01/2017
1	Cytochrome P-450 CYP3AIBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 02/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	NucleotidesIBA 01/2016
1	Fenofibrate (CiL)FDA LinkGeneric 09/2015
1	HCV NS3-4A Protease InhibitorsIBA 08/2014
1	telaprevirIBA 08/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2014
1	Indicators and Reagents (Reagents)IBA 06/2014
1	Transaminases (Aminotransferases)IBA 12/2013
1	Methadone (Dolophine)FDA LinkGeneric 03/2008
1	RNA (Ribonucleic Acid)IBA 03/2007
1	Rilpivirine (TMC-278)IBA 08/2006